Also trades as: NGLFINE.BO (BSE) · $vol 0M

₹2,900.00 ($30.15)

-9.50 (-0.33%)

NSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 68 · ₹17.9B mcap · 2M float · 1.07% daily turnover

Analysis Technicals Weather Peers

Revenue

$5.0B +36.0% ▲

5Y CAGR: +14.2%

Gross Profit

$1.8B -5.1% ▼

5Y CAGR: +2.9%

Operating Income

$531M +136.8% ▲

5Y CAGR: -6.9%

Net Income

$481M +127.8% ▲

5Y CAGR: -3.2%

EPS (Diluted)

$77.90 +127.8% ▲

5Y CAGR: -3.2%

EBITDA

$874M +158.1% ▲

5Y CAGR: -0.2%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$3.2B	$2.8B	$3.4B	$3.7B	$5.0B
YoY Growth	+23.1%	-12.4%	+21.8%	+8.7%	+36.0%
Cost of Revenue	$1.5B	$1.4B	$1.7B	$1.8B	$3.2B
Gross Profit	$1.7B	$1.4B	$1.7B	$1.9B	$1.8B
Gross Margin	52.2%	49.5%	50.1%	50.5%	35.2%
R&D Expenses	$17M	$24M	$47M	$50M	$0
SG&A Expenses	$206M	$209M	$218M	$577M	$1.2B
Operating Expenses	$1.1B	$233M	$1.3B	$555M	$1.2B
Operating Income	$578M	$237M	$421M	$224M	$531M
Operating Margin	18.2%	8.5%	12.4%	6.1%	10.6%
Interest Expense	$19M	$18M	$18M	$23M	$45M
Income Before Tax	$666M	$274M	$544M	$277M	$634M
Tax Expense	$167M	$69M	$131M	$66M	$152M
Net Income	$499M	$205M	$413M	$211M	$481M
Net Margin	15.7%	7.4%	12.2%	5.7%	9.6%
EPS (Diluted)	$80.77	$33.18	$66.88	$34.19	$77.90
EBITDA	$789M	$405M	$679M	$339M	$874M
Shares Outstanding	6M	6M	6M	6M	6M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$908M	$935M	$891M	$950M	$1.0B	$1.2B	$1.3B	$1.5B
Cost of Revenue	$472M	$442M	$435M	$478M	$519M	$573M	$818M	$929M
Gross Profit	$436M	$493M	$456M	$472M	$523M	$630M	$457M	$563M
Gross Margin	48.0%	52.7%	51.1%	49.7%	50.2%	52.4%	35.9%	37.7%
R&D Expenses	$0	$0	$0	$89M	$0	$0	$0	$0
SG&A Expenses	$119M	$0	$20M	$142M	$256M	$301M	$286M	$400M
Operating Expenses	$372M	$408M	$436M	$142M	$456M	$509M	$286M	$400M
Operating Income	$63M	$85M	$20M	$329M	$67M	$121M	$171M	$164M
Operating Margin	7.0%	9.1%	2.2%	34.7%	6.4%	10.0%	13.4%	11.0%
Interest Expense	$4M	$3M	$6M	$10M	$12M	$12M	$11M	$10M
Income Before Tax	$118M	$133M	$13M	$11M	$118M	$130M	$207M	$178M
Tax Expense	$26M	$35M	-$113K	$5M	$26M	$33M	$50M	$43M
Net Income	$92M	$98M	$13M	$5M	$92M	$96M	$157M	$135M
Net Margin	10.2%	10.5%	1.4%	0.6%	8.9%	8.0%	12.3%	9.0%
EPS (Diluted)	$14.92	$15.88	$2.07	$0.88	$14.96	$15.58	$25.40	$21.83
EBITDA	$94M	$167M	$50M	$61M	$173M	$192M	$269M	$239M
Shares Outstanding	6M	6M	6M	6M	6M	6M	6M	6M

NGLFINE.NS NSE